Medication formulary policies represent a key determinant of access to medication and can be leveraged to advance pharmacoequity and health equity writ large.
Chethan Bachireddy, MD, MSc
Advertisement
Articles by Chethan Bachireddy, MD, MSc
As the coronavirus disease 2019 (COVID-19) pandemic threatens to worsen the opioid crisis, payers must rapidly deploy policies to ensure care for individuals with opioid use disorder.
Advertisement
Latest Updated Articles
Advancing Health Equity Through Medication Formulary PolicyPublished: July 11th 2023 | Updated:
- Payer Strategies to Ensure Access to Care for Individuals With Opioid Use Disorder During COVID-19
Published: October 21st 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Value-Based Care Interventions and Management of CKD Progression
5
